News | Nipro

NIPRO Completes Patient Enrollment in GREAT U.S. Pivotal Trial for the Golazo™ Peripheral Atherectomy System

NIPRO meets Mayor of Lleida to announce €25 million Investment in Regional Renal Care Manufacturing

NIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance

NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States

Supply Continuity Update

Avantec Vascular, a NIPRO Company, Announces FDA 510(k) Clearance of Thrombectomy System

Pharmaceutical Packaging

ISO 17025 Certification for Technical Services Glass Laboratory

President’s Greetings for 2026

NIPRO on the Move 2025: When Movement Became a Shared Mission

NIPRO Partners with Diaverum for the First LiniXia Installation in the UK

NIPRO’s Global Vision Featured in the Los Angeles Times

FDA IDE Approval for INSYTE nOCT Brain Aneurysm Trial

NIPRO’s Contribution to Healthcare Transformation in Morocco

NIPRO and Medical Device HQ collaborate to enhance skills in design control

Benefits Of IVUS Plus Near-infrared Spectroscopy In Detecting And Managing Vulnerable Plaques

From Mesa to the World: Two NIPRO Colleagues Bring CARE to Life